AARD

AS OF

Nov 13, 04:59 PM (EDT)

Price

$10.84

Change

+$0.11 (+1.03%)

Capitalization

235.59M

19 days until earnings call

Intraday BUY SELL Signals

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

AARD

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Aardvark Therapeutics (AARD) Ownership - Who owns Aardvark Therapeutics?

Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Details

Group

Domestic Stock Funds

Fundamentals

AARD

Capitalization

236M

P/E Ratio

N/A

Risk (Beta)

N/A

Dividend Yield

N/A

Total Cash

142M

Total Cash/Share

6.54

Total Debt

645K

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

Revenue

ROE

N/A

Book Value

137M

P/B Ratio

1.72

Cash Flow

N/A

Earnings

-1.69

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

Current Ratio

14.04

Current Revenue Per Employee

N/A

Dividends Per Share - Security

N/A

EBITDA

-40.83M

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

-31.22

Shares Held By Institutions

131M

Shares Outstanding - Current

21.7M

Total Liabilities

10.6M

Total Volume MTD

N/A

Value

Gain YTD

N/A

View a ticker or compare two or three

Compare

AARD

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. AARD showed earnings on August 13, 2025. You can read more about the earnings report here.

View AI-Driven Trading for AARD

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details